Neoadjuvant chemotherapy for primary cutaneous/soft tissue angiosarcoma: Determining tumor behavior prior to surgical resection

Journal of Surgical Oncology
Jacqueline OxenbergJohn M Kane

Abstract

Given the propensity for hematogenous metastases, neoadjuvant chemotherapy (NAC) could treat occult metastatic disease early, potentially improving survival and better defining which primary angiosarcomas (AS) benefit from surgical resection. A retrospective comparison was performed of 23 patients with resectable, localized cutaneous/soft tissue primary AS treated with surgery alone (S, n = 13) or NAC followed by surgery (NAC-S, n = 12). Primary sites included breast/chest (n = 9), head/neck (n = 9), extremity (n = 3), and other (n = 2). 23% S versus 40% NAC-S had prior radiation (RT). NAC regimens were paclitaxel (n = 6) or gemcitabine/docetaxel (n = 4). Seventy percent were high grade. Distant metastases were found in 17% after NAC. Non-primary wound closure was required in 54 %S versus 30%NAC-S (P = 0.4). R0 resections were achieved in 85% S versus 80% NAC-S (30% had a complete pathologic response). Two-year local recurrence (LR)-free, disease-free, and overall survivals were 67.1, 38.5, and 61.5% for S versus 68.6, 54.9, and 68.6% for NAC-S (P = 0.52, 0.67, and 0.58). The mean number of surgical resections/patient to maintain local control was 1.8 S versus 1.3 NAC-S (P = 0.06). NAC for primary AS was well tolerated. Althoug...Continue Reading

References

Dec 11, 1991·Archives of Surgery·M S KarpehM F Brennan
Apr 1, 1990·Annals of Surgery·C M PezziM M Romsdahl
Jun 11, 2005·Cancer·Keith M Skubitz, Philip A Haddad
Feb 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William G KraybillUNKNOWN Radiation Therapy Oncology Group Trial 9514
Mar 16, 2007·Annals of Surgical Oncology·John A AbrahamSam S Yoon
Jun 2, 2007·Cancer·Taimur SherAna M Gonzalez-Angulo
Nov 3, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J FayetteJ Y Blay
Sep 6, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M SchlemmerJ Y Blay
Sep 24, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicolas PenelJean-Yves Blay
Nov 14, 2008·International Journal of Radiation Oncology, Biology, Physics·Walter RhombergRichard Pötter
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert G MakiGary K Schwartz
Jun 25, 2009·Annals of Surgical Oncology·G LahatD Lev
Jul 30, 2009·Annals of Surgery·Pierre A ClavienMasatoshi Makuuchi
Dec 31, 2010·Annals of Diagnostic Pathology·Jorge Albores-SaavedraFredy Chablé-Montero
Apr 6, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S StacchiottiP G Casali
Jan 31, 2012·The Oncologist·Isabelle Ray-CoquardUNKNOWN French Sarcoma Group (GSF/GETO)
Aug 23, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M AgulnikR S Benjamin

❮ Previous
Next ❯

Citations

Aug 21, 2016·The Surgical Clinics of North America·Cary HsuParvin F Peddi
Oct 18, 2016·Current Opinion in Cardiology·Chiara Lestuzzi
Jun 14, 2019·Annals of Plastic Surgery·Nedhal A AlqumberMin-Kyu Kang
Aug 11, 2017·Clinical Sarcoma Research·R B Cohen-HallalehA J Hayes
Aug 19, 2020·Cancers·Kimberley M HeinhuisWinan J van Houdt
Jan 26, 2021·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·V VerdinS Markiewicz
Jul 17, 2019·Journal of the American Academy of Dermatology·Rosalynn R Z ConicBrian R Gastman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.